Fig. 5From: Role of 18 fluorine-fluorodeoxyglucose positron emission tomography/computed tomography in assessment of neoadjuvant chemotherapy response in breast cancer patients56 years old female patient with history of right breast cancer submitted for MRM followed by chemotherapy presented with left breast cancer (invasive ductal carcinoma, luminal B subtype). Axial CECT and fused PET/CT images (a, b) revealed metabolically active left breast soft tissue mass lesion achieving 3 SULpeak. On follow-up after completion of chemotherapy, stationary appearance of the left breast mass regarding size and FDG uptake is noted in both axial CECT and fused PET/CT images (c, d) denoting stationary disease and stationary metabolic diseaseBack to article page